Medicare billing address
CMS Medicare provider billing file
911 Ligonier St Ste 104Latrobe, PA 15650
CMS public data · NPI 1669607693
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Stephanie M Rubino, MD
Specialty
Credential
MD
NPI
1669607693
Primary source state
PA
Data retrieval date
July 28, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Stephanie M Rubino, MD from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
911 Ligonier St Ste 104CMS Doctors & Clinicians file
1 Mellon WayCMS Doctors & Clinicians file
522 W Newton StIn the 2024 CMS provider billing file, this NPI had 608 Medicare beneficiaries and 5,940 total services. The average beneficiary age was 74, and the average HCC risk score was 1.3.
Total Medicare allowed amount
$229,144.55
Total Medicare payment amount
$180,944.36
Medicare beneficiaries
608
Total services
5,940
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hyperlipidemia
75%
CMS beneficiary-panel share
Hypertension
75%
CMS beneficiary-panel share
Ischemic heart disease
32%
CMS beneficiary-panel share
Diabetes
30%
CMS beneficiary-panel share
Chronic kidney disease
28%
CMS beneficiary-panel share
Anxiety
28%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Injection, onabotulinumtoxina, 1 unit | 2,800 | $6.26 |
| Detection test by nucleic acid for organism, amplified probe technique | 520 | $34.39 |
| Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 319 | $90.20 |
| Urinalysis, manual test | 297 | $3.41 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 234 | $127.26 |
| Detection test for candida species (yeast), amplified probe technique | 200 | $34.39 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 125 | $79.03 |
| Detection test by nucleic acid for multiple organisms, amplified probe(s) technique | 120 | $68.80 |
| New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more | 104 | $167.60 |
| Ultrasound measurement of bladder capacity after voiding | 66 | $10.88 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1669607693. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Oxybutynin Chloride Er | Oxybutynin Chloride | 160 | 281.7 | $1,925.61 |
| 2 | Tamsulosin Hcl | Tamsulosin Hcl | 152 | 427.3 | $2,382.46 |
| 3 | Cephalexin | Cephalexin | 149 | 171 | $605.91 |
| 4 | Finasteride | Finasteride | 83 | 233.3 | $1,564.45 |
| 5 | Estradiol | Estradiol | 82 | 223.1 | $5,478.00 |
| 6 | Methenamine Hippurate | Methenamine Hippurate | 74 | 186 | $7,612.70 |
| 7 | Ciprofloxacin Hcl | Ciprofloxacin Hcl | 64 | 64 | $187.53 |
| 8 | Myrbetriq | Mirabegron | 64 | 120 | $53,280.62 |
| 9 | Solifenacin Succinate | Solifenacin Succinate | 57 | 91 | $1,685.44 |
| 10 | Gemtesa | Vibegron | 52 | 82 | $36,989.23 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Graduation year
2009
Group/practice field
Excela Health Physician Practices, Inc
Telehealth reported
Not reported
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.